JP2005097319A5 - - Google Patents

Download PDF

Info

Publication number
JP2005097319A5
JP2005097319A5 JP2004347900A JP2004347900A JP2005097319A5 JP 2005097319 A5 JP2005097319 A5 JP 2005097319A5 JP 2004347900 A JP2004347900 A JP 2004347900A JP 2004347900 A JP2004347900 A JP 2004347900A JP 2005097319 A5 JP2005097319 A5 JP 2005097319A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004347900A
Other versions
JP2005097319A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2005097319A publication Critical patent/JP2005097319A/ja
Publication of JP2005097319A5 publication Critical patent/JP2005097319A5/ja
Withdrawn legal-status Critical Current

Links

JP2004347900A 1993-05-12 2004-11-30 Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ Withdrawn JP2005097319A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6169993A 1993-05-12 1993-05-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP6525508A Division JPH08510240A (ja) 1993-05-12 1994-05-03 Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ

Publications (2)

Publication Number Publication Date
JP2005097319A JP2005097319A (ja) 2005-04-14
JP2005097319A5 true JP2005097319A5 (ja) 2005-11-04

Family

ID=22037528

Family Applications (3)

Application Number Title Priority Date Filing Date
JP6525508A Pending JPH08510240A (ja) 1993-05-12 1994-05-03 Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ
JP2004347900A Withdrawn JP2005097319A (ja) 1993-05-12 2004-11-30 Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ
JP2005152406A Withdrawn JP2005325126A (ja) 1993-05-12 2005-05-25 Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP6525508A Pending JPH08510240A (ja) 1993-05-12 1994-05-03 Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2005152406A Withdrawn JP2005325126A (ja) 1993-05-12 2005-05-25 Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ

Country Status (7)

Country Link
US (6) US7135185B1 (ja)
EP (2) EP1421951A3 (ja)
JP (3) JPH08510240A (ja)
AT (1) ATE249838T1 (ja)
CA (1) CA2162557C (ja)
DE (1) DE69433160T2 (ja)
WO (1) WO1994026306A1 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08510240A (ja) * 1993-05-12 1996-10-29 カイロン コーポレイション Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ
DE19504302A1 (de) * 1995-02-09 1996-08-14 Boehringer Mannheim Gmbh Methode zur serologischen Typisierung mittels typspezifischer Antigene
US6110465A (en) * 1995-06-07 2000-08-29 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences in diagnostic methods and vaccines
KR970065713A (ko) * 1996-03-19 1997-10-13 성재갑 C형 간염 바이러스(일본형)의 분비형 외피 단백질 1 및 2
GB9810756D0 (en) 1998-05-19 1998-07-15 Angeletti P Ist Richerche Bio Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
WO2001021807A1 (en) * 1999-09-23 2001-03-29 The Government Of The United States Of America As Represented By The Secretary, Department Of Health Services Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
CA2391843C (en) * 1999-11-19 2011-10-18 Csl Limited Hcv vaccine compositions
KR20020091093A (ko) * 2000-02-14 2002-12-05 미쯔비시 파마 코포레이션 씨형간염 치료제
US20110097332A1 (en) * 2007-08-06 2011-04-28 Martina Buck Composition and Method of Use for HCV Immunization
US8314371B2 (en) 2008-11-06 2012-11-20 Applied Materials, Inc. Rapid thermal processing chamber with micro-positioning system
US20100322943A1 (en) 2009-06-17 2010-12-23 Thomas Cantor Therapeutic and diagnostic affinity purified specific polyclonal antibodies
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
GB201415714D0 (en) * 2014-09-05 2014-10-22 Medical Res Council Antibodies and antigen binding fragments thereof

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146633A (en) * 1973-05-07 2000-11-14 The Ohio State University Method for treatment of antigenically modified polypeptides
US4491632A (en) 1979-10-22 1985-01-01 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
US4444887A (en) 1979-12-10 1984-04-24 Sloan-Kettering Institute Process for making human antibody producing B-lymphocytes
CA1188985A (en) 1980-07-01 1985-06-18 Edward J. Stott Production of viral antigens
EP0043718B1 (en) 1980-07-07 1984-11-28 National Research Development Corporation Improvements in or relating to cell lines
US4341761A (en) 1980-07-25 1982-07-27 E. I. Du Pont De Nemours And Company Antibodies to immunogenic peptides and their use to purify human fibroblast interferon
US4466917A (en) 1981-02-12 1984-08-21 New York University Malaria vaccine
US4493890A (en) 1981-03-23 1985-01-15 Miles Laboratories, Inc. Activated apoglucose oxidase and its use in specific binding assays
US4399121A (en) 1981-11-04 1983-08-16 Miles Laboratories, Inc. Iodothyronine immunogens and antibodies
US4427783A (en) 1981-12-14 1984-01-24 Hoffmann-La Roche Inc. Immunoassay of thymosin α1
DE3382547D1 (de) 1983-01-12 1992-05-27 Chiron Corp Sekretorische expression in eukaryoten.
CA1341302C (en) 1983-02-22 2001-10-09 Rae Lyn Burke Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0164556B1 (en) 1984-05-11 1994-03-02 Chiron Corporation Enhanced yeast transcription employing hybrid promoter region constructs
US4722840A (en) 1984-09-12 1988-02-02 Chiron Corporation Hybrid particle immunogens
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4629783A (en) 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
CA1319101C (en) 1986-09-03 1993-06-15 Marta Iris Sabara Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules
IE62868B1 (en) 1987-11-18 1995-03-08 Chiron Corp Hepatitis C virus
US5252459A (en) 1988-09-23 1993-10-12 Abbott Laboratories Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles
UA50829C2 (uk) * 1989-03-17 2002-11-15 Чірон Корпорейшн Очищений поліпептид, що містить антиген вірусу гепатиту с, полінуклеотид, вектор, клітини, система експресії, моноклональне антитіло, препарат поліклональних антитіл, нуклеотидна проба, аналітичні набори, спосіб виявлення нуклеїнових кислот, способи імуноаналізу, вакцина, спосіб одержання антитіл
RO113059B1 (ro) 1989-05-18 1998-03-30 Chiron Corp Polinucleotida capabila de hibridizare pe o secventa hcv, metoda pentru detectarea unei secvente hcv si procedeu de eliminare a hcv din sange
JPH0832638B2 (ja) 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
US5308750A (en) * 1989-12-22 1994-05-03 Abbott Laboratories Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
US5747239A (en) * 1990-02-16 1998-05-05 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
CA2047792C (en) 1990-07-26 2002-07-02 Chang Y. Wang Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
SK286106B6 (sk) * 1990-11-08 2008-03-05 Novartis Vaccines & Diagnostics, Inc. Spôsob vykonávania imunodiagnostickej skúšky na detekciu protilátky proti vírusu hepatitídy C
US6274148B1 (en) * 1990-11-08 2001-08-14 Chiron Corporation Hepatitis C virus asialoglycoproteins
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
HU227547B1 (en) 1991-06-24 2011-08-29 Novartis Vaccines & Diagnostic Hepatitis c virus (hcv) polypeptides
DK0608261T3 (da) * 1991-09-13 2003-03-17 Chiron Corp Sammensætninger med immunreaktivt hepatitis C virus polypeptid
EP0583481B1 (en) 1992-02-05 1999-11-10 Daikin Industries, Ltd. Polytetrafluoroethylene powder for molding
DE69324751T3 (de) 1992-03-06 2005-03-17 Naamloze Vennootschap Innogenetics S.A. Verfahren zur bestimmung von peptiden, die immunologisch wichtigen epitopen von hcv zugehörig sind
JPH08510240A (ja) * 1993-05-12 1996-10-29 カイロン コーポレイション Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ
US6555114B1 (en) 1993-11-04 2003-04-29 Innogenetics N.V. Immunodominant human T-cell epitopes of hepatitis C virus
US5709995A (en) 1994-03-17 1998-01-20 The Scripps Research Institute Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
MXPA02012424A (es) * 2000-06-15 2003-04-25 Chiron Corp Ensayo de combinacion de antigenos/anticuerpos para el virus de hepatitis c.

Similar Documents

Publication Publication Date Title
BE2015C038I2 (ja)
BRPI0518216C1 (ja)
BRPI0515516B8 (ja)
BR122015024347A2 (ja)
BRPI0508002A (ja)
JP2005290580A5 (ja)
BR122018073034B8 (ja)
BRPI0508029A (ja)
BRPI0419105B8 (ja)
JP2005311698A5 (ja)
JP2005097319A5 (ja)
JP2004291636A5 (ja)
BRPI0508026A (ja)
JP2004320026A5 (ja)
JP2006033580A5 (ja)
JP2006023212A5 (ja)
JP2005257493A5 (ja)
JP2006007472A5 (ja)
BRPI0508033A (ja)
AT501137B8 (ja)
AT500847B8 (ja)
CN300736473S (zh) 洗手盆
CN300736470S (zh) 抽水马桶
CN300729373S (zh) 包装盒（曲面的蛤壳式）
CN300731631S (zh) 衣架